Poland· PL-100041674
Maść na odciski
A medicinal product containing acidum lacticum + acidum salicylicum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Acidum lacticum + Acidum salicylicum
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990668014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acidum lacticum + acidum salicylicum in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4831cc86-33e4-4862-af6f-35373bd41c42 GET /v1/drugs/4831cc86-33e4-4862-af6f-35373bd41c42?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(400 mg + 100 mg)/g",
"packaging": "05909990668014 ¦ OTC ¦ 45891\n1 tuba 10 g",
"substance": "Acidum salicylicum 400 mg/g + Acidum lacticum 100 mg/g",
"common_name": "Acidum lacticum + Acidum salicylicum",
"pl_product_id": "100041674",
"pozwolenie_nr": "06680",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about acidum lacticum + acidum salicylicum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.